Iana Parvanova

1.0k total citations
8 papers, 762 citations indexed

About

Iana Parvanova is a scholar working on Immunology, Oncology and Parasitology. According to data from OpenAlex, Iana Parvanova has authored 8 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Oncology and 3 papers in Parasitology. Recurrent topics in Iana Parvanova's work include Herpesvirus Infections and Treatments (2 papers), Immune Response and Inflammation (2 papers) and Toxoplasma gondii Research Studies (2 papers). Iana Parvanova is often cited by papers focused on Herpesvirus Infections and Treatments (2 papers), Immune Response and Inflammation (2 papers) and Toxoplasma gondii Research Studies (2 papers). Iana Parvanova collaborates with scholars based in Switzerland, Germany and United States. Iana Parvanova's co-authors include Jonathan C. Howard, Jens Zerrahn, Sascha Martens, Gaby Reichmann, Gareth Griffiths, Maria Leptin, Cemalettin Bekpen, Diane M. Dunn, Julia P. Hunn and Christoph Rohde and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Genome biology.

In The Last Decade

Iana Parvanova

8 papers receiving 757 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iana Parvanova Switzerland 7 376 357 340 162 87 8 762
Niclas Hitziger Sweden 9 304 0.8× 445 1.2× 182 0.5× 180 1.1× 27 0.3× 10 648
Ajesh Maewal United States 12 286 0.8× 160 0.4× 658 1.9× 557 3.4× 111 1.3× 13 1.1k
Christoph Lippuner Switzerland 12 198 0.5× 223 0.6× 184 0.5× 158 1.0× 30 0.3× 21 676
Julia P. Hunn Germany 14 873 2.3× 906 2.5× 466 1.4× 283 1.7× 24 0.3× 14 1.4k
Mathieu Gissot France 18 324 0.9× 532 1.5× 194 0.6× 369 2.3× 28 0.3× 40 954
Caylin G. Winchell United States 10 165 0.4× 119 0.3× 167 0.5× 128 0.8× 35 0.4× 12 498
Taishi Kimura United States 10 270 0.7× 237 0.7× 286 0.8× 264 1.6× 23 0.3× 14 753
Olivia Giddings United States 11 454 1.2× 491 1.4× 126 0.4× 126 0.8× 16 0.2× 19 798
Mariana R. Dominguez Brazil 16 232 0.6× 206 0.6× 192 0.6× 101 0.6× 28 0.3× 29 566
Ryan Finethy United States 13 282 0.8× 132 0.4× 412 1.2× 444 2.7× 27 0.3× 14 923

Countries citing papers authored by Iana Parvanova

Since Specialization
Citations

This map shows the geographic impact of Iana Parvanova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iana Parvanova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iana Parvanova more than expected).

Fields of papers citing papers by Iana Parvanova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iana Parvanova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iana Parvanova. The network helps show where Iana Parvanova may publish in the future.

Co-authorship network of co-authors of Iana Parvanova

This figure shows the co-authorship network connecting the top 25 collaborators of Iana Parvanova. A scholar is included among the top collaborators of Iana Parvanova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iana Parvanova. Iana Parvanova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Parvanova, Iana, Lorna Rettig, Alexander Knuth, & Steve Pascolo. (2011). The form of NY-ESO-1 antigen has an impact on the clinical efficacy of anti-tumor vaccination. Vaccine. 29(22). 3832–3836. 15 indexed citations
2.
Rettig, Lorna, et al.. (2010). Gemcitabine depletes regulatory T‐cells in human and mice and enhances triggering of vaccine‐specific cytotoxic T‐cells. International Journal of Cancer. 129(4). 832–838. 65 indexed citations
3.
Parvanova, Iana, Sabrina Epiphânio, Abdul H. Fauq, et al.. (2009). A Small Molecule Inhibitor of Signal Peptide Peptidase Inhibits Plasmodium Development in the Liver and Decreases Malaria Severity. PLoS ONE. 4(4). e5078–e5078. 24 indexed citations
4.
Zeng, Jia, Iana Parvanova, & Jonathan C. Howard. (2009). A Dedicated Promoter Drives Constitutive Expression of the Cell-Autonomous Immune Resistance GTPase, Irga6 (IIGP1) in Mouse Liver. PLoS ONE. 4(8). e6787–e6787. 6 indexed citations
5.
Schmuckli‐Maurer, Jacqueline, Carlo Casanova, Iana Parvanova, et al.. (2009). Expression Analysis of the Theileria parva Subtelomere-Encoded Variable Secreted Protein Gene Family. PLoS ONE. 4(3). e4839–e4839. 38 indexed citations
6.
Coers, Jörn, Isaac Bernstein-Hanley, Iana Parvanova, et al.. (2008). Chlamydia muridarum Evades Growth Restriction by the IFN-γ-Inducible Host Resistance Factor Irgb10. The Journal of Immunology. 180(9). 6237–6245. 95 indexed citations
7.
Bekpen, Cemalettin, Julia P. Hunn, Christoph Rohde, et al.. (2005). The interferon-inducible p47 (IRG) GTPases in vertebrates: loss of the cell autonomous resistance mechanism in the human lineage. Genome biology. 6(11). R92–R92. 236 indexed citations
8.
Martens, Sascha, Iana Parvanova, Jens Zerrahn, et al.. (2005). Disruption of Toxoplasma gondii Parasitophorous Vacuoles by the Mouse p47-Resistance GTPases. PLoS Pathogens. 1(3). e24–e24. 283 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026